All Vaccinology articles
-
NewsStudy shows why mRNA-based COVID-19 vaccines can cause myocarditis
Investigators have unearthed the biological process by which mRNA-based vaccines for COVID-19 can cause heart damage in some young men and adolescents — and they’ve shown a possible route to reducing its likelihood.
-
NewsNew method to accelerate vaccine and drug development for norovirus
Researchers have developed a simple and efficient system for understanding the functions of specific norovirus genes, providing new avenues for developing antivirals and vaccines.
-
NewsInstitutions team up to advance first AI-designed mRNA vaccine against deadly tick-borne disease
Scientists are developing what could become the world’s first mRNA vaccine against severe fever with thrombocytopenia syndrome (SFTS)—a tick-borne viral disease associated with this condition.
-
NewsWhat are the new guidelines for infant hepatitis B vaccination?
Public health expert and infectious disease physician Janet A. Jokela comments after the Advisory Committee on Immunization Practices of the CDC voted to discontinue its decades-long recommendation for universal vaccination against hepatitis B beginning at birth.
-
NewsStudy shows robust immune responses to H5N8 avian influenza vaccine
A new study shows that the MF59-adjuvanted A(H5N8) vaccine induced strong immune responses, including both functional antibodies and memory T-cell responses, against the vaccine virus, as well as against H5 viruses that have caused recent outbreaks in Europe and the United States.
-
NewsStudy links childhood vaccination to lower risk of drug-resistant bacteria
Children in Guatemala who received a common vaccine that helps prevent pneumonia were less likely to carry antibiotic-resistant bacteria, according to a new study examining whether rotavirus (RV) and pneumococcal (PCV13) vaccines reduce gut colonization by a group of bacteria.
-
NewsPresurgical vaccine may prevent orthopedic device infections
Researchers have developed a novel presurgical vaccine strategy that may prevent dangerous infections in patients receiving hip, knee, and other joint replacements, creating an injectable scaffold designed to stimulate the immune system.
-
NewsMeasles deaths down 88% since 2000, but cases surge
Global immunization efforts have led to an 88% drop in measles deaths between 2000 and 2024, according to a new report from the World Health Organization (WHO). Nearly 59 million lives have been saved by the measles vaccine since 2000.
-
NewsGlobal Virus Network issues warning on the Marburg virus outbreak in Ethiopia
The Global Virus Network (GVN) has issued a statement on the newly confirmed outbreak of Marburg virus disease (MVD) in southern Ethiopia. This represents the country’s first documented outbreak of Marburg virus and raises urgent public health, research, and surveillance imperatives.
-
NewsFractional-dose vaccines can save millions during shortages
New research shows that using smaller, fractional doses of vaccines can significantly reduce infections during epidemics, especially when vaccine supply, delivery, or administration capacity is limited.
-
NewsExpanding seasonal immunization access could minimize off-season RSV epidemics
Researchers found differences in how respiratory syncytial virus spreads among children in rural versus urban communities and concluded that year-round immunizations would minimize risks of large seasonal outbreaks.
-
NewsSnakebites: COVID vaccine tech could limit venom damage
The same technology used in COVID-19 vaccines could help prevent muscle damage from snakebites, according to scientists who say it could be even more useful for other conditions where toxins cause harm gradually, such as blocking harmful toxins produced by bacteria during infections.
-
NewsNew vaccine against a deadly virus acts fast and protects for over a year
A research team has developed a vaccine made from a non-infectious version of the Crimean-Congo hemorrhagic fever virus that protects quickly and provides long-lasting immunity.
-
NewsNew flu strain underscores urgent need for vigilance, vaccination, and investment in virus science
Virologists have issued a statement on the emergence of a new influenza A (H3N2) variant known as H3N2 subclade K that is spreading rapidly and may contribute to a more intense flu season worldwide. Public health agencies have reported sharp week-over-week increases in cases driven by this subclade.
-
NewsNew research confirms HPV vaccination prevents cervical cancer
Two new Cochrane reviews show strong and consistent evidence that HPV vaccines are effective in preventing cervical cancer and pre-cancerous changes, especially when given to young people before they are exposed to the virus.
-
NewsScripps Research scientists receive $1.1 million to advance AI modeling for HIV vaccine development
Scripps Research scientists will purchase high-performance computing equipment to accelerate the identification of more effective HIV vaccine candidates through enhanced computational infrastructure, reduced data-processing bottlenecks, and state-of-the-art artificial intelligence (AI) technology.
-
NewsApriori Bio and A*STAR Infectious Diseases Labs Announce strategic partnership to advance next generation influenza vaccines
Apriori Bio and the Agency for Science, Technology and Research Infectious Diseases Labs (A*STAR IDL) announced a strategic research partnership to co-develop and evaluate next generation self-amplifying RNA (saRNA) vaccines targeting seasonal and pandemic influenza.
-
NewsPig disease vaccine effectiveness linked to T cell response
A new study shows that the effectiveness of current vaccines against porcine reproductive and respiratory syndrome virus (PRRSV) is due to the response of T cells against the disease, rather than the production of antibodies. The work is an important step in identifying specific targets for vaccines on a rapidly mutating virus.
-
NewsProtecting infants against respiratory syncytial virus this winter — ECDC issues advice
ECDC has issued rapid scientific advice for policymakers and public health authorities on ways to mitigate the impact of RSV disease among infants through immunisation and to support intensified efforts to protect them from RSV across Europe.
-
NewsBiomedical Sciences researcher receives nearly $7 million in federal grants to fight STIs
Cynthia Nau Cornelissen, a Distinguished University Professor and associate director of the Institute for Biomedical Sciences at Georgia State University, has received nearly $7 million in two, five-year federal grants to develop vaccines and therapeutics to combat sexually transmitted infections (STIs).